Home › Research › Inflammation and the immune system
Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review
Julijana Zoran Conic, Alexandra Chetty, Lily Zhiying Chen, Audrey Marsh, Sean Barry, Rodney Pattabhi, Thomas M. Reske, Erwin A. Aguilar et al.. Aging Medicine, 2025-02-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
ABSTRACT Objectives Alzheimer's disease (AD) is a prevalent age‐related neurodegenerative disease that affects millions of individuals in the United States. Neuroinflammation is a driver of the neurodegenerative changes that characterize AD, prompting interest in how inflammation can be modulated for treatment and prevention. Methods ICD‐10 codes were quarried from electronic medical records to identify patients diagnosed with AD from 2012 to 2020. The patients were then divided into those who used systemic steroids and those who did not before the progression of their disease. Data on medication prescribed was used to measure the disease's progression. Clinical findings and laboratory results were collected to build a propensity score. Patients were followed until disease progression, death, or the last available visit. Kaplan–Meier curves and hazard ratios adjusted for the propensity score were used to compare the two groups. Results Of the 459 patients identified, 77 were included in the study, and 13 used steroids. Of the 77 patients included in the study, 59 had progression of their disease, and of those, five used steroids. The median time to progression was 408.00 (191.00, 979.00) days for the overall sample. The hazard ratio (HR) comparing the group using steroids to those not using steroids was 0.26 with a 95% CI of (0.1013, 0.673) and a p value of 0.00064. Conclusions In our study, steroid use delayed the progression of dementia. Further study is needed to outline how steroids and anti‐inflammatory medications can be used in the treatment and prevention of AD.
What this study adds
Evidence grade: Low
The record lists 459 participants. In a retrospective chart review of 77 patients, those who used systemic steroids had a lower hazard ratio for disease progression than those who did not. This is a small retrospective study, so it cannot show that steroids treat or prevent Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Conic, J. Z., Chetty, A., Chen, L. Z., Marsh, A., Barry, S., Pattabhi, R., et al. (2025). Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review. Aging Medicine. https://doi.org/10.1002/agm2.70004
Vancouver
Conic JZ, Chetty A, Chen LZ, Marsh A, Barry S, Pattabhi R, et al. Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review. Aging Medicine. 2025. doi:10.1002/agm2.70004. PMID: 39968005.
BibTeX
@article{conic2025-39968005,
author = {Conic, Julijana Zoran and Chetty, Alexandra and Chen, Lily Zhiying and Marsh, Audrey and Barry, Sean and Pattabhi, Rodney and Reske, Thomas M. and Aguilar, Erwin A. and others},
title = {{Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review}},
journal = {Aging Medicine},
year = {2025},
doi = {10.1002/agm2.70004},
pmid = {39968005},
url = {https://doi.org/10.1002/agm2.70004}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Clinical findings and laboratory results were collected to build a propensity score.
- Results Of the 459 patients identified, 77 were included in the study, and 13 used steroids.
- The median time to progression was 408.00 (191.00, 979.00) days for the overall sample.
Why it matters
In a retrospective chart review of 77 patients, those who used systemic steroids had a lower hazard ratio for disease progression than those who did not. This is a small retrospective study, so it cannot show that steroids treat or prevent Alzheimer's disease.
Study details
- Participants459
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Aging Medicine) |
| Journal's citation record | 0 / 4 | Aging Medicine: journal h-index 33 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 459 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Lobna Abo Ali: h-index 11 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Louisiana State University Health Sciences Center New Orleans: institution h-index 503 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39968005) |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Inflammation and the immune system from nearby years
Also in Inflammation and the immune system
144 studies in the library are filed under Inflammation and the immune system with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Inflammation and the immune system hub.